Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2026 Filed Feb 13, 2026 18:03 UTC |
Rothman PaulDirector
|
Exercise / conversionCommon Stock | 897 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000079 · form4.xml · nonDerivative · entry 1 Rothman Paul · CIK 0001601332 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:58 UTC |
Wengel Kathryn EDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 897 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000078 · form4.xml · derivative · entry 2 Wengel Kathryn E · CIK 0001745955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773 Underlying: Common Stock · 897 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 11, 2026. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 11, 2026. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:58 UTC |
Wengel Kathryn EDirector
|
Exercise / conversionCommon Stock | 897 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000078 · form4.xml · nonDerivative · entry 1 Wengel Kathryn E · CIK 0001745955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:56 UTC |
Parham Richelle PDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 897 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000076 · form4.xml · derivative · entry 2 Parham Richelle P · CIK 0001550078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773 Underlying: Common Stock · 897 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 11, 2026. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 11, 2026. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:56 UTC |
Parham Richelle PDirector
|
Exercise / conversionCommon Stock | 897 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000076 · form4.xml · nonDerivative · entry 1 Parham Richelle P · CIK 0001550078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:55 UTC |
NEUPERT PETER MDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 897 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000075 · form4.xml · derivative · entry 2 NEUPERT PETER M · CIK 0001237566 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773 Underlying: Common Stock · 897 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 11, 2026. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 11, 2026. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:55 UTC |
NEUPERT PETER MDirector
|
Exercise / conversionCommon Stock | 897 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000075 · form4.xml · nonDerivative · entry 1 NEUPERT PETER M · CIK 0001237566 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:53 UTC |
Kong GarhengDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 897 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000074 · form4.xml · derivative · entry 2 Kong Garheng · CIK 0001435183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773 Underlying: Common Stock · 897 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 11, 2026. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 11, 2026. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:53 UTC |
Kong GarhengDirector
|
Exercise / conversionCommon Stock | 897 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000074 · form4.xml · nonDerivative · entry 1 Kong Garheng · CIK 0001435183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:52 UTC |
Kliphouse Kirsten MarieDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 897 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000073 · form4.xml · derivative · entry 2 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773 Underlying: Common Stock · 897 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 11, 2026. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 11, 2026. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:52 UTC |
Kliphouse Kirsten MarieDirector
|
Exercise / conversionCommon Stock | 897 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000073 · form4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:48 UTC |
Davis Jeffrey A.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 897 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000072 · form4.xml · derivative · entry 2 Davis Jeffrey A. · CIK 0001648477 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773 Underlying: Common Stock · 897 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 11, 2026. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 11, 2026. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:48 UTC |
Davis Jeffrey A.Director
|
Exercise / conversionCommon Stock | 897 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000072 · form4.xml · nonDerivative · entry 1 Davis Jeffrey A. · CIK 0001648477 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:47 UTC |
ANDERSON KERRII BDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 897 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000071 · form4.xml · derivative · entry 4 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773 Underlying: Common Stock · 897 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 11, 2026. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 11, 2026. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:47 UTC |
ANDERSON KERRII BDirector
|
Exercise / conversionCommon Stock | 897 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000071 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:44 UTC |
Meltzer Jonathan CEVP, Operations
|
GrantRestricted Stock Unit · Derivative | 620 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000069 · form4.xml · derivative · entry 3 Meltzer Jonathan C · CIK 0002103998 · EVP, Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,937 Underlying: Common Stock · 620 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F6 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:44 UTC |
Meltzer Jonathan CEVP, Operations
|
GrantNon-qualified Stock Options · Derivative | 1,900 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000069 · form4.xml · derivative · entry 2 Meltzer Jonathan C · CIK 0002103998 · EVP, Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,900 Underlying: Common Stock · 1,900 shares Expires 2036-02-09 F2 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:44 UTC |
Meltzer Jonathan CEVP, Operations
|
SaleCommon Stock | 91 | $276.79 | $25,187.89 |
DisclosureSEC source: 0000920148-26-000069 · form4.xml · nonDerivative · entry 1 Meltzer Jonathan C · CIK 0002103998 · EVP, Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,696.3256 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:45 UTC |
Schechter Adam HDirector · President & CEO
|
GrantRestricted Stock Unit · Derivative | 10,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000070 · form4.xml · derivative · entry 2 Schechter Adam H · CIK 0001376841 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,870 Underlying: Common Stock · 10,440 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:45 UTC |
Schechter Adam HDirector · President & CEO
|
GrantNon-qualified Stock Options · Derivative | 31,700 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000070 · form4.xml · derivative · entry 1 Schechter Adam H · CIK 0001376841 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,700 Underlying: Common Stock · 31,700 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:43 UTC |
Kyle Kathryn WEVP, Chief Legal Officer
|
GrantRestricted Stock Unit · Derivative | 880 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000068 · form4.xml · derivative · entry 2 Kyle Kathryn W · CIK 0002103996 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,480 Underlying: Common Stock · 880 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:43 UTC |
Kyle Kathryn WEVP, Chief Legal Officer
|
GrantNon-qualified Stock Options · Derivative | 2,700 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000068 · form4.xml · derivative · entry 1 Kyle Kathryn W · CIK 0002103996 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,700 Underlying: Common Stock · 2,700 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:42 UTC |
Vaughn Bryan TEVP, Diagnostics
|
GrantRestricted Stock Unit · Derivative | 730 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000067 · form4.xml · derivative · entry 2 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,354 Underlying: Common Stock · 730 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:42 UTC |
Vaughn Bryan TEVP, Diagnostics
|
GrantNon-qualified Stock Options · Derivative | 2,200 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000067 · form4.xml · derivative · entry 1 Vaughn Bryan T · CIK 0002103999 · EVP, Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,200 Underlying: Common Stock · 2,200 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:41 UTC |
Wang Julia AijunChief Financial Officer, EVP
|
GrantRestricted Stock Unit · Derivative | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000066 · form4.xml · derivative · entry 2 Wang Julia Aijun · CIK 0001860279 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,824 Underlying: Common Stock · 2,350 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:41 UTC |
Wang Julia AijunChief Financial Officer, EVP
|
GrantNon-qualified Stock Options · Derivative | 7,100 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000066 · form4.xml · derivative · entry 1 Wang Julia Aijun · CIK 0001860279 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,100 Underlying: Common Stock · 7,100 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:40 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
GrantRestricted Stock Unit · Derivative | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000065 · form4.xml · derivative · entry 2 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,664 Underlying: Common Stock · 440 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:40 UTC |
Wilkinson Peter JSVP, Chief Accounting Officer
|
GrantNon-qualified Stock Options · Derivative | 1,300 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000065 · form4.xml · derivative · entry 1 Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 1,300 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:39 UTC |
Oyegunwa AkinboladeEVP, CIO & CTO
|
GrantRestricted Stock Unit · Derivative | 810 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000064 · form4.xml · derivative · entry 2 Oyegunwa Akinbolade · CIK 0002042869 · EVP, CIO & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,420 Underlying: Common Stock · 810 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:39 UTC |
Oyegunwa AkinboladeEVP, CIO & CTO
|
GrantNon-qualified Stock Options · Derivative | 2,400 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000064 · form4.xml · derivative · entry 1 Oyegunwa Akinbolade · CIK 0002042869 · EVP, CIO & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,400 Underlying: Common Stock · 2,400 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:36 UTC |
Summy Amy B.EVP, Chief Marketing Officer
|
GrantRestricted Stock Unit · Derivative | 620 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000063 · form4.xml · derivative · entry 2 Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,534 Underlying: Common Stock · 620 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:36 UTC |
Summy Amy B.EVP, Chief Marketing Officer
|
GrantNon-qualified Stock Options · Derivative | 1,900 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000063 · form4.xml · derivative · entry 1 Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,900 Underlying: Common Stock · 1,900 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:35 UTC |
GRAHAM ANITA ZEVP, CHRO
|
GrantRestricted Stock Unit · Derivative | 1,360 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000062 · form4.xml · derivative · entry 2 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,757 Underlying: Common Stock · 1,360 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:35 UTC |
GRAHAM ANITA ZEVP, CHRO
|
GrantNon-qualified Stock Options · Derivative | 4,100 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000062 · form4.xml · derivative · entry 1 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:34 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
GrantRestricted Stock Unit · Derivative | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000061 · form4.xml · derivative · entry 2 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,230 Underlying: Common Stock · 1,100 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:34 UTC |
Bailey Megan D.EVP, Pres, Central Labs & Intl
|
GrantNon-qualified Stock Options · Derivative | 3,300 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000061 · form4.xml · derivative · entry 1 Bailey Megan D. · CIK 0001975682 · EVP, Pres, Central Labs & Intl 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,300 Underlying: Common Stock · 3,300 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:32 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
GrantRestricted Stock Unit · Derivative | 2,020 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000060 · form4.xml · derivative · entry 2 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,910 Underlying: Common Stock · 2,020 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:32 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
GrantNon-qualified Stock Options · Derivative | 6,100 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000060 · form4.xml · derivative · entry 1 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,100 Underlying: Common Stock · 6,100 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:28 UTC |
Kong GarhengDirector
|
GrantRestricted Stock Unit · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000059 · form4.xml · derivative · entry 1 Kong Garheng · CIK 0001435183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670 Underlying: Common Stock · 773 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:24 UTC |
Rothman PaulDirector
|
GrantRestricted Stock Unit · Derivative | 733 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000057 · form4.xml · derivative · entry 1 Rothman Paul · CIK 0001601332 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670 Underlying: Common Stock · 733 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:09 UTC |
Sampson John HDirector
|
GrantRestricted Stock Unit · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000053 · form4.xml · derivative · entry 1 Sampson John H · CIK 0002110483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773 Underlying: Common Stock · 773 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:07 UTC |
Parham Richelle PDirector
|
GrantRestricted Stock Unit · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000050 · form4.xml · derivative · entry 1 Parham Richelle P · CIK 0001550078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670 Underlying: Common Stock · 773 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:08 UTC |
Wengel Kathryn EDirector
|
GrantRestricted Stock Unit · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000052 · form4.xml · derivative · entry 1 Wengel Kathryn E · CIK 0001745955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670 Underlying: Common Stock · 773 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:05 UTC |
NEUPERT PETER MDirector
|
GrantRestricted Stock Unit · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000048 · form4.xml · derivative · entry 1 NEUPERT PETER M · CIK 0001237566 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670 Underlying: Common Stock · 773 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:03 UTC |
Kliphouse Kirsten MarieDirector
|
GrantRestricted Stock Unit · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000046 · form4.xml · derivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670 Underlying: Common Stock · 773 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:02 UTC |
Davis Jeffrey A.Director
|
GrantRestricted Stock Unit · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000044 · form4.xml · derivative · entry 1 Davis Jeffrey A. · CIK 0001648477 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670 Underlying: Common Stock · 773 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:00 UTC |
Bulto Carulla VictorDirector
|
GrantRestricted Stock Unit · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000042 · form4.xml · derivative · entry 1 Bulto Carulla Victor · CIK 0002098937 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 909 Underlying: Common Stock · 773 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 15:59 UTC |
ANDERSON KERRII BDirector
|
GrantRestricted Stock Unit · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000041 · form4.xml · derivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670 Underlying: Common Stock · 773 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2026 Filed Feb 10, 2026 20:18 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
Tax withholdingCommon Stock | 32 | $274.01 | $8,768.32 |
DisclosureSEC source: 0000920148-26-000033 · form4.xml · nonDerivative · entry 6 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,077.9234 F3 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 09, 2026 Filed Feb 10, 2026 20:18 UTC |
Caveney Brian JEVP, Pres of ED, CMO & CSO
|
Tax withholdingCommon Stock | 148 | $274.01 | $40,553.48 |
DisclosureSEC source: 0000920148-26-000033 · form4.xml · nonDerivative · entry 5 Caveney Brian J · CIK 0001717915 · EVP, Pres of ED, CMO & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,109.9234 F3 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.